SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

ALKSSell

Alkermes plc.

David Joseph Gaffin · EVP, CLO, Alkermes, Inc.

$83K−0.9%Oct 2
ALKSSell

Alkermes plc.

David Joseph Gaffin · EVP, CLO, Alkermes, Inc.

$98K−0.9%Sep 3
ALKSSell

Alkermes plc.

Craig C. Hopkinson · EVP R&D, Chief Medical Officer

$423K−12.1%Sep 1
ALKSSell

Alkermes plc.

Christian Todd Nichols · SVP and Chief Commercial Officer

$373K−6.9%Aug 17
ALKSSell

Alkermes plc.

Nancy Lynn Md Snyderman · Director

$2.2M−74.3%Aug 3
ALKSSell

Alkermes plc.

Craig C. Hopkinson · EVP R&D, Chief Medical Officer

$437K−11.5%Aug 3
ALKSSell

Alkermes plc.

David Joseph Gaffin · EVP, CLO, Alkermes, Inc.

$99K−0.9%Aug 3
ALKSSell

Alkermes plc.

David Joseph Gaffin · EVP, CLO, Alkermes, Inc.

$110K−0.9%Jul 6
ALKSSell

Alkermes plc.

Craig C. Hopkinson · EVP R&D, Chief Medical Officer

$464K−10.9%Jul 1
ALKSSell

Alkermes plc.

Christopher I Wright · Director

$90K−7.2%Jun 13
ALKSSell

Alkermes plc.

David Joseph Gaffin · EVP, CLO, Alkermes, Inc.

$88K−0.9%Jun 4
ALKSSell

Alkermes plc.

Craig C. Hopkinson · EVP R&D, Chief Medical Officer

$375K−10.4%Jun 1
ALKSSell

Alkermes plc.

Samuel Joseph Parisi · VP, Finance (Interim PAO)

$687K−67.8%May 29
ALKSSell

Alkermes Plc.

David Joseph Gaffin · EVP, CLO, Alkermes, Inc.

$68K−1.0%May 4
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$301K−10.0%May 1
ALKSSell

Alkermes Plc.

David Joseph Gaffin · EVP, CLO, Alkermes, Inc.

$70K−1.0%Apr 6
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$320K−10.0%Apr 1
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$267K−9.0%Mar 4
ALKSSell

Alkermes Plc.

David Joseph Gaffin · EVP, CLO, Alkermes, Inc.

$120K−2.0%Mar 4
ALKSSell

Alkermes Plc.

Samuel Joseph Parisi · VP, Finance (Interim PAO)

$202K−47.0%Mar 4
ALKSSell

Alkermes Plc.

Christian Todd Nichols · SVP and Chief Commercial Officer

$180K−5.0%Mar 4
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$305K−13.0%Feb 2
ALKSSell

Alkermes Plc.

Shane Cooke · Director

$2.1M−37.0%Feb 2
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$150K−7.0%Jan 8
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$112K−6.0%Jan 2
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$112K−5.0%Dec 5
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$117K−6.0%Dec 1
ALKSSell

Alkermes Plc.

Christian Todd Nichols · SVP and Chief Commercial Officer

$152K−8.0%Nov 27
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$1.8M−41.0%Nov 12
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$309K−10.0%Nov 6
ALKSSell

Alkermes Plc.

Christian Todd Nichols · SVP and Chief Commercial Officer

$293K−14.0%Mar 18
ALKSSell

Alkermes Plc.

Samuel Joseph Parisi · VP, Finance (Interim PAO)

$76K−25.0%Feb 27
ALKSSell

Alkermes Plc.

Cato T Laurencin · Director

$86K−15.0%Feb 16
ALKSSell

Alkermes Plc.

Cato T Laurencin · Director

$84K−26.0%Jun 8
ALKSSell

Alkermes Plc.

Cato T Laurencin · Director

$88K−27.0%Jun 7
ALKSSell

Alkermes Plc.

Christian Todd Nichols · SVP and Chief Commercial Officer

$785K−40.0%May 30
ALKSSell

Alkermes Plc.

Nancy Wysenski · Director

$1.3M−60.0%May 10
ALKSSell

Alkermes Plc.

Christian Todd Nichols · SVP and Chief Commercial Officer

$211K−26.0%Jun 21
ALKSSell

Alkermes Plc.

Michael J Landine · SVP, Corp Dev., Alkermes, Inc.

$1.5M−18.0%May 19
ALKSSell

Alkermes Plc.

Michael J Landine · SVP, Corp Dev., Alkermes, Inc.

$680K−10.0%May 12
ALKSSell

Alkermes Plc.

Richard F Pops · Dir, CEO, Alkermes plc

$9.7M−26.0%May 6
ALKSSell

Alkermes Plc.

Michael J Landine · SVP, Corp Dev., Alkermes, Inc.

$715K−10.0%May 3
ALKSSell

Alkermes Plc.

Shane Cooke · Director

$292K−10.0%May 3
ALKSSell

Alkermes Plc.

Shane Cooke · Director

$279K−10.0%Apr 27
ALKSSell

Alkermes Plc.

Blair Curtis Jackson · EVP and COO

$1.5M−36.0%Apr 22
ALKSSell

Alkermes Plc.

Shane Cooke · Director

$289K−10.0%Apr 19
ALKSSell

Alkermes Plc.

Shane Cooke · Director

$293K−10.0%Apr 12
ALKSSell

Alkermes Plc.

Shane Cooke · Director

$282K−10.0%Apr 5
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$297K−40.0%Feb 24
ALKSSell

Alkermes Plc.

Craig C. Hopkinson · EVP R, D, Chief Medical Office

$58K−7.0%Feb 23

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.